Reuters logo
BRIEF-Alexion Pharmaceuticals names Paul Clancy as CFO
June 13, 2017 / 8:41 PM / 6 months ago

BRIEF-Alexion Pharmaceuticals names Paul Clancy as CFO

June 13 (Reuters) - Alexion Pharmaceuticals Inc

* Alexion names Paul Clancy chief financial officer

* Alexion Pharmaceuticals Inc - Clancy will succeed Dave Anderson, who will continue to serve as CFO until july 31, 2017

* For past 16 years, Clancy has been employed by Biogen where he has served as CFO for last ten years

* Alexion Pharmaceuticals Inc - Clancy most recently served as executive vice president, finance and CFO and a member of executive committee of Biogen Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below